Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Gutian Xiao

Photo of Gutian Xiao
Title(s)Professor of Immunology and Immune Therapeutics
SchoolKeck School of Medicine of Usc
Address1333 San Pablo St.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard
    Other Positions
    Title(s)Culture and Engagement Director


    Collapse Research 
    Collapse research activities and funding
    Mechanistic difference of NF-kappaB in lung physiology and tumorigenesis
    NIH R01CA258614Aug 24, 2022 - Jul 31, 2027
    Role: Co-Principal Investigator
    Structural and molecular dissection of NF-kappaB regulation by the ubiquitin E3 ligase PDLIM2 in lung innate immunity and diseases
    NIH R01GM144890Mar 10, 2022 - Feb 28, 2026
    Role: Co-Principal Investigator
    Faithful mouse modeling of human lung cancer
    NIH R21CA259706Apr 1, 2021 - Mar 31, 2023
    Role: Principal Investigator
    PDLIM2 as a cancer and chemosensitizing target
    NIH R01CA172090Jul 1, 2013 - Apr 30, 2019
    Role: Principal Investigator
    Modeling ETP-ALL in mouse
    NIH R21CA175252May 1, 2013 - Apr 30, 2016
    Role: Principal Investigator
    HTLV deregulation of NF-kappaB2 p100 processing in tumor
    NIH R01CA116616Jul 1, 2006 - May 31, 2012
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. An Advanced Single-Cell RNA Sequencing (scRNA-seq) Protocol Utilizing Custom-Designed Multiplexing. Bio Protoc. 2026 May 05; 16(9):e5678. Gao F, Liu X, Sun F, Xiao Y, Xiao G, Qu Z. PMID: 42111707; PMCID: PMC13156703.
      View in: PubMed   Mentions:
    2. Enhanced HIF-1α cooperation by a human RORγt mutant potentiates Th17 pathogenicity. Cell Rep. 2026 Mar 17; 45(4):117123. Dong P, Liu L, Yu J, Li N, Davidorf B, Shen S, Bouch R, Zhang J, Ho D, Xiao G, Akbari O, Zhang B, He Z. PMID: 41849346.
      View in: PubMed   Mentions:    Fields:    
    3. PDLIM2 repression: a common mechanism in viral lung infection. Immunohorizons. 2026 Mar 10; 10(3). Gao F, Chen YW, Shapiro SD, Xiao G, Qu Z. PMID: 41904702; PMCID: PMC13168810.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Alveolar epithelial NF-κB/RelA guards the lung against bacterial infection. J Immunol. 2026 Feb 09; 215(2). Zhang H, Xiao Y, Gao F, Le TH, Shapiro SD, Xiao G, Qu Z. PMID: 41764725.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    5. PDLIM2 in Lung Adenocarcinoma Metastasis. bioRxiv. 2025 Dec 07. Gao F, Xiao Y, Zhang H, Shapiro SD, Qu Z, Xiao G. PMID: 41573961; PMCID: PMC12822692.
      View in: PubMed   Mentions:
    6. Myeloid PDLIM2 repression as a common mechanism of infection susceptibility in lung diseases. Front Immunol. 2025; 16:1669117. Gao F, Liu X, Sun F, Xiao Y, Xiao G, Qu Z. PMID: 41346604; PMCID: PMC12672342.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    7. PDLIM2 Repression: A Common Mechanism in Viral Lung Infection. bioRxiv. 2025 Sep 17. Gao F, Chen YW, Shapiro SD, Xiao G, Qu Z. PMID: 41000764; PMCID: PMC12458227.
      View in: PubMed   Mentions: 1  
    8. NanoPDLIM2-Based Combination Therapy for Lung Cancer Treatment in Mouse Preclinical Studies. Bio Protoc. 2025 Sep 05; 15(17):e5437. Le TH, Sun F, Xiao G, Qu Z. PMID: 40948895; PMCID: PMC12423285.
      View in: PubMed   Mentions: 1  
    9. Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2. Elife. 2024 Dec 24; 12. Sun F, Yan P, Xiao Y, Zhang H, Shapiro SD, Xiao G, Qu Z. PMID: 39718207; PMCID: PMC11668523.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    10. PDLIM2 is a novel E5 ubiquitin ligase enhancer that stabilizes ROC1 and recruits the ROC1-SCF ubiquitin ligase to ubiquitinate and degrade NF-κB RelA. Cell Biosci. 2024 Jul 30; 14(1):99. Sun F, Xiao G, Qu Z. PMID: 39080804; PMCID: PMC11287889.
      View in: PubMed   Mentions: 2  
    11. Critical and distinct roles of cell type-specific NF-κB2 in lung cancer. JCI Insight. 2024 02 22; 9(4). Sun F, Xiao Y, Shapiro SD, Qu Z, Xiao G. PMID: 38385745; PMCID: PMC10967404.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    12. Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2. bioRxiv. 2024 Jan 09. Sun F, Yan P, Xiao Y, Zhang H, Shapiro SD, Xiao G, Qu Z. PMID: 37546791; PMCID: PMC10402062.
      View in: PubMed   Mentions: 1  
    13. Alveolar Macrophages Inherently Express Programmed Death-1 Ligand 1 for Optimal Protective Immunity and Tolerance. J Immunol. 2021 07 01; 207(1):110-114. Sun F, Li L, Xiao Y, Gregory AD, Shapiro SD, Xiao G, Qu Z. PMID: 34135059; PMCID: PMC8674373.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    14. Hydrogel-based electrodes for selective cervical vagus nerve stimulation. J Neural Eng. 2021 04 20; 18(5). Horn CC, Forssell M, Sciullo M, Harms JE, Fulton S, Mou C, Sun F, Simpson TW, Xiao G, Fisher LE, Bettinger C, Fedder GK. PMID: 33784636.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    15. PDLIM2 repression by ROS in alveolar macrophages promotes lung tumorigenesis. JCI Insight. 2021 03 08; 6(5). Li L, Sun F, Han L, Liu X, Xiao Y, Gregory AD, Shapiro SD, Xiao G, Qu Z. PMID: 33539325; PMCID: PMC8021114.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    16. Methods to Detect NF-κB Activity in Tumor-Associated Macrophage (TAM) Populations. Methods Mol Biol. 2021; 2366:213-241. Sun F, Qu Z, Xiao G. PMID: 34236641.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    17. Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer. J Immunother Cancer. 2020 05; 8(1). Sun F, Guo ZS, Gregory AD, Shapiro SD, Xiao G, Qu Z. PMID: 32461344; PMCID: PMC7254155.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    18. Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance. Nat Commun. 2019 11 22; 10(1):5324. Sun F, Li L, Yan P, Zhou J, Shapiro SD, Xiao G, Qu Z. PMID: 31757943; PMCID: PMC6876573.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    19. NF-κB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8+ T cells for tumor promotion. Oncoimmunology. 2018; 7(6):e1435250. Li L, Han L, Sun F, Zhou J, Ohaegbulam KC, Tang X, Zang X, Steinbrecher KA, Qu Z, Xiao G. PMID: 29872577; PMCID: PMC5980414.
      View in: PubMed   Mentions: 30     Fields:    
    20. Murine Bronchoalveolar Lavage. Bio Protoc. 2017 May 20; 7(10). Sun F, Xiao G, Qu Z. PMID: 29082285; PMCID: PMC5659634.
      View in: PubMed   Mentions: 42  
    21. Isolation of Murine Alveolar Type II Epithelial Cells. Bio Protoc. 2017 May 20; 7(10). Sun F, Xiao G, Qu Z. PMID: 29082286; PMCID: PMC5659635.
      View in: PubMed   Mentions: 7  
    22. Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation. Cancer Immunol Res. 2017 03; 5(3):257-268. Zhou J, Qu Z, Sun F, Han L, Li L, Yan S, Stabile LP, Chen LF, Siegfried JM, Xiao G. PMID: 28108629; PMCID: PMC5334370.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    23. Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer. Cancer Res. 2015 Aug 15; 75(16):3209-15. Qu Z, Sun F, Zhou J, Li L, Shapiro SD, Xiao G. PMID: 26122841; PMCID: PMC4537823.
      View in: PubMed   Mentions: 66     Fields:    Translation:AnimalsCells
    24. Systematic detection of noncanonical NF-κB activation. Methods Mol Biol. 2015; 1280:121-54. Qu Z, Xiao G. PMID: 25736747.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    25. Differential roles of STAT3 in the initiation and growth of lung cancer. Oncogene. 2015 Jul; 34(29):3804-3814. Zhou J, Qu Z, Yan S, Sun F, Whitsett JA, Shapiro SD, Xiao G. PMID: 25284582; PMCID: PMC4387125.
      View in: PubMed   Mentions: 50     Fields:    Translation:AnimalsCells
    26. NF-kappaB activation: Tax sumoylation is out, but what about Tax ubiquitination? Retrovirology. 2012 Sep 25; 9:78. Xiao G. PMID: 23009565; PMCID: PMC3470980.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    27. PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease. Cell Biosci. 2012 Jun 25; 2(1):23. Qu Z, Fu J, Ma H, Zhou J, Jin M, Mapara MY, Grusby MJ, Xiao G. PMID: 22731402; PMCID: PMC3543335.
      View in: PubMed   Mentions: 29  
    28. Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway. J Biol Chem. 2011 Aug 19; 286(33):29249-29260. Imanishi Y, Hu B, Xiao G, Yao X, Cheng SY. PMID: 21680733; PMCID: PMC3190731.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    29. Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesis. Viruses. 2011 Jun; 3(6):714-49. Qu Z, Xiao G. PMID: 21743832; PMCID: PMC3131208.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    30. NF-κB and cancer: a paradigm of Yin-Yang. Am J Cancer Res. 2011; 1(2):192-221. Xiao G, Fu J. PMID: 21969033; PMCID: PMC3180046.
      View in: PubMed   Mentions: 58  
    31. The tumor suppressor gene WWOX links the canonical and noncanonical NF-κB pathways in HTLV-I Tax-mediated tumorigenesis. Blood. 2011 Feb 03; 117(5):1652-61. Fu J, Qu Z, Yan P, Ishikawa C, Aqeilan RI, Rabson AB, Xiao G. PMID: 21115974; PMCID: PMC3318777.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    32. Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer. J Biol Chem. 2010 Apr 16; 285(16):11786-92. Qu Z, Fu J, Yan P, Hu J, Cheng SY, Xiao G. PMID: 20185823; PMCID: PMC2852914.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    33. DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target. Cancer Res. 2010 Mar 01; 70(5):1766-72. Qu Z, Yan P, Fu J, Jiang J, Grusby MJ, Smithgall TE, Xiao G. PMID: 20145149; PMCID: PMC3003295.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    34. Human T-cell leukemia virus type I-mediated repression of PDZ-LIM domain-containing protein 2 involves DNA methylation but independent of the viral oncoprotein tax. Neoplasia. 2009 Oct; 11(10):1036-41. Yan P, Qu Z, Ishikawa C, Mori N, Xiao G. PMID: 19794962; PMCID: PMC2745669.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    35. PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation. Blood. 2009 Apr 30; 113(18):4370-80. Yan P, Fu J, Qu Z, Li S, Tanaka T, Grusby MJ, Xiao G. PMID: 19131544; PMCID: PMC2676091.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    36. SUMO1 modification of NF-kappaB2/p100 is essential for stimuli-induced p100 phosphorylation and processing. EMBO Rep. 2008 Sep; 9(9):885-90. Vatsyayan J, Qing G, Xiao G, Hu J. PMID: 18617892; PMCID: PMC2529344.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    37. Targeting autophagic regulation of NFkappaB in HTLV-I transformed cells by geldanamycin: implications for therapeutic interventions. Autophagy. 2007 Nov-Dec; 3(6):600-3. Yan P, Qing G, Qu Z, Wu CC, Rabson A, Xiao G. PMID: 17671417.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    38. Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation. Cell Res. 2007 Jun; 17(6):520-30. Qing G, Yan P, Qu Z, Liu H, Xiao G. PMID: 17563756.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCells
    39. Autophagy and NF-kappaB: fight for fate. Cytokine Growth Factor Rev. 2007 Jun-Aug; 18(3-4):233-43. Xiao G. PMID: 17485237; PMCID: PMC2810660.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    40. Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promoters. Proc Natl Acad Sci U S A. 2007 Mar 27; 104(13):5324-9. Qing G, Qu Z, Xiao G. PMID: 17363471; PMCID: PMC1838492.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    41. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK). Cell Res. 2006 Nov; 16(11):895-901. Qing G, Yan P, Xiao G. PMID: 17088896.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansAnimalsCells
    42. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev. 2006 Aug; 17(4):281-93. Xiao G, Rabson AB, Young W, Qing G, Qu Z. PMID: 16793322.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCells
    43. Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100. J Biol Chem. 2005 Dec 09; 280(49):40578-82. Qing G, Qu Z, Xiao G. PMID: 16223731.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    44. Essential role of IkappaB kinase alpha in the constitutive processing of NF-kappaB2 p100. J Biol Chem. 2005 Mar 18; 280(11):9765-8. Qing G, Xiao G. PMID: 15677466.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    45. Regulation of NF-kappa B2 p100 processing by its cis-acting domain. J Biol Chem. 2005 Jan 07; 280(1):18-27. Qing G, Qu Z, Xiao G. PMID: 15485830.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    46. Tax deregulation of NF-kappaB2 p100 processing involves both beta-TrCP-dependent and -independent mechanisms. J Biol Chem. 2004 Oct 22; 279(43):44563-72. Qu Z, Qing G, Rabson A, Xiao G. PMID: 15310758.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    47. Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. J Biol Chem. 2004 Jul 16; 279(29):30099-105. Xiao G, Fong A, Sun SC. PMID: 15140882.
      View in: PubMed   Mentions: 146     Fields:    Translation:HumansCells
    Gutian's Networks
    Concepts (214)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (3)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-23-g6a590cb1 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.